Humanwell Healthcare (Group) Co.,Ltd.SSE: 600079

(600079)"Humanwell Healthcare (Group) Co., Ltd."Announcement on Obtaining the Marketing Authorization for Sugammadex Sodium Injection from the UK Medicines and Healthcare Products Regulatory Agency (MHRA)

· Issued by Humanwell Healthcare (Group) Co.,Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 600079 · · 1 page · Chinese

Summary by 6ix AI

Humanwell Healthcare (Group) Co.,Ltd. announced that its subsidiary has received marketing authorization for Sugammadex Sodium Injection from the UK Medicines and Healthcare Products Regulatory Agency.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/600079humanwell-healthcare-group-co-ltdannouncement-on-obtaining-the-marketing-authorization-for-sugammadex-sodium-injection-from-the-uk-medicines-and-healthcare-products-regulatory-agency-mhra

Release

Announcement on Obtaining the Marketing Authorization for Sugammadex Sodium Injection from the UK Medicines and Healthcare Products Regulatory Agency (MHRA)

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Humanwell Healthcare (Group) Co.,Ltd. on 6ix

Story so far

Earlier from Humanwell Healthcare (Group) Co.,Ltd

Later from Humanwell Healthcare (Group) Co.,Ltd

All Humanwell Healthcare (Group) Co.,Ltd news releases